Related Experiment Video
Updated: Aug 5, 2026

Quantifying Glomerular Permeability of Fluorescent Macromolecules Using 2-Photon Microscopy in Munich Wistar Rats
Published on: April 17, 2013
[The analysis of plasma beta 2-microglobulin concentration in patients with chronic renal failure treated by
1Katedra i Klinika Nefrologii Pediatrycznej Akademii Medycznej we Wrocławiu.
Abstract:
Plasma beta 2-microglobulin concentrations increase in long-term dialyzed patients. This rise correlates with impairment of excretion and degradation by inefficient kidneys and also with increased synthesis of this protein during standard hemodialysis. In extreme cases, in particular in patients treated by hemodialysis for a long time, when their plasma beta 2-concentration rises significantly, the protein can be deposited in tissues. This study reports the results of determining serum beta 2-microglobulin levels in 14 patients with chronic renal failure treated by hemodialysis. The average age of patients at the beginning of the study was 16 years. All patients were hemodialyzed with cuprophane membranes. Determinations of beta 2-microglobulin levels were repeated after 6, 12 and 24 months. The results show that serum beta 2-microglobulin levels rose during this period of hemodialysis therapy.
Insights
Serum beta 2-microglobulin levels rise in patients undergoing long-term hemodialysis. This increase is linked to impaired kidney function and increased protein synthesis during dialysis treatment.
Area of Science:
- Nephrology
- Biochemistry
Background:
- Plasma beta 2-microglobulin (β2M) concentrations are elevated in patients with chronic renal failure undergoing long-term hemodialysis.
- This elevation is attributed to reduced renal excretion and degradation, alongside increased synthesis of β2M during hemodialysis.
Purpose of the Study:
- To investigate the longitudinal changes in serum β2M levels in patients with chronic renal failure undergoing hemodialysis.
- To assess the correlation between hemodialysis duration and serum β2M concentration.
Main Methods:
- Serum β2M levels were measured in 14 patients with chronic renal failure (average age 16 years) at baseline.
- Measurements were repeated at 6, 12, and 24 months of hemodialysis therapy.
- All patients were treated with cuprophane membranes for hemodialysis.
Main Results:
- Serum β2M levels showed a significant increase over the 24-month study period.
- The observed rise in β2M suggests a progressive accumulation of this protein in patients on long-term hemodialysis.
Conclusions:
- Long-term hemodialysis therapy is associated with a progressive increase in serum β2M levels.
- This finding highlights the potential for β2M deposition in tissues, particularly in patients with prolonged dialysis treatment.
- Monitoring β2M levels may be crucial for managing long-term hemodialysis patients.
Related Concept Videos
Renal Clearance
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Serum Studies: Renal Function Tests

